Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(OP:
NYMXF
)
0.0402
-0.0098 (-19.60%)
Streaming Delayed Price
Updated: 12:05 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
250
Open
0.0402
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0500
Today's Range
0.0402 - 0.0402
52wk Range
0.0322 - 0.1495
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nymox Announces Dismissal of Delaware Action Against Ascella
March 11, 2025
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX Announces Trading Resumed and New Listing on OTCQB Market
December 17, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Performance
YTD
-13.7%
-13.7%
1 Month
-26.9%
-26.9%
3 Month
-53.4%
-53.4%
6 Month
-40.5%
-40.5%
1 Year
-55.3%
-55.3%
More News
Read More
Nymox Announces Filing of Annual Report
August 30, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Annual Report
July 18, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Required to Resubmit Application to DKMA
July 16, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
March 27, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox December 27 Message to Shareholders
December 27, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
November 30, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
November 21, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
November 09, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
November 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
November 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
November 02, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
October 31, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
October 27, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
October 26, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
September 25, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Reports Completion of $2 Million Private Placement
August 29, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox Announces $2 Million Private Placement
August 02, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO
July 31, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Frequently Asked Questions
Is NYMXF publicly traded?
Yes, NYMXF is publicly traded.
What exchange does NYMXF trade on?
NYMXF trades on the OTC Traded
What is the ticker symbol for NYMXF?
The ticker symbol for NYMXF is NYMXF on the OTC Traded
What is the current price of NYMXF?
The current price of NYMXF is 0.0402
When was NYMXF last traded?
The last trade of NYMXF was at 02/13/26 12:05 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.